Clinical Trials in Salt Lake City

Showing 7861-7880 of 16,694 trials

Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines

NCT02236312

The primary objective of the study is to evaluate the efficacy in wrinkle reduction of a single treatment of three different doses of botulinum toxin compared to placebo, in the treatment of moderate to very severe glabellar frown lines.

Glabellar Frown Lines

Galderma R&D359 participantsStarted Sep 2014

Birmingham, Alabama, United States • Mobile, Alabama, United States • San Diego, California, United States +5 more locations

TERMINATEDPhase 1/2< 1 mile

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

NCT02601209

This phase I/II trial studies the side effects and best dose of sapanisertib and to see how well it works compared to pazopanib hydrochloride in treating patients with sarcoma that is too large to be removed (locally advanced) or has spread to other areas of the body (metastatic). Sapanisertib and pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.

High Grade SarcomaMetastatic LeiomyosarcomaMetastatic Malignant Peripheral Nerve Sheath Tumor+16 more

National Cancer Institute (NCI)151 participantsStarted Nov 2015

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Anchorage, Alaska, United States +457 more locations

Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Find Trials by Condition in Salt Lake City

Genomic Translation for Amyotrophic Lateral Sclerosis Care

Social Needs and Resources in the Evaluation and Enhancement of Discharge Support

3T MRI CIED Post-Approval Study

REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

Phase 2 Study to Assess Safety, Tolerability and Efficacy of Once Weekly SC Pemziviptadil (PB1046) in Subjects With Symptomatic PAH

A Study of APTO-253 in Patients With Relapsed or Refractory AML or MDS

Phase 2 Study on Effects of Obeticholic Acid (OCA) on Lipoprotein Metabolism in Participants With Primary Biliary Cirrhosis

Open-Label Extension and Safety Study of Talazoparib

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

Clobetasol Propionate Spray Versus Vehicle Spray for the Management of Moderate to Severe Plaque Psoriasis of the Scalp

Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Platysmal Bands

Efficacy/Safety/Subject Satisfaction/Duration of Response of Clobetasol Propionate Spray vs Ointment in Plaque Psoriasis

A Study of Prexasertib (LY2606368) in Platinum-Resistant or Refractory Recurrent Ovarian Cancer

Study of Cosibelimab in Subjects With Relapsed or Refractory Lymphoma

Seasonal Influenza HA DNA With Trivalent Inactivated Vaccine (TIV) Administered ID or IM in Healthy Adults 18-70 Years

Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis

Post Market Clinical Protocol - Xtremity Polymer Prosthetic Socket System

Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis